Some job relocations are less cumbersome than others.
When Jedd Wolchok left Memorial Sloan Kettering Cancer Center after more than a quarter century, he crossed East 68th Street to Weill Cornell campus, where he is now the director of the Sandra and Edward Meyer Cancer Center.
Wolchok, former chief of the Immuno-Oncology Service and the Lloyd J. Old/Virginia and Daniel K. Ludwig Chair in Clinical Investigation at MSK, who started the Weill Cornell job Sept. 12, 2022, didn’t even have to change his academic affiliation. He has been a Weill Cornell Medicine faculty member throughout his time at MSK.
“I had the great privilege of working for 26 years at Memorial Sloan Kettering, and really could not be more grateful for the time and opportunities that I had there to really see a wholesale change in the way that immunotherapy is perceived, and to really be supported by amazing colleagues,” Wolchok said to The Cancer Letter.
“And I guess about a year or two ago, I began to get several offers from prestigious institutions to think about what the next steps in my career might look like, specifically around leading a cancer center. And after having gone through some leadership development training, I really believed that this was something that was of great interest to me.
“And the opportunity literally next door, at Weill Cornell Medicine, was very attractive for a lot of reasons.”
Wolchok’s mandate at Weill Cornell includes formulating a strategy for pursuing an NCI designation, he said.
Options include forming a consortium or pursuing the designation solo.
